BRODA Acne Spa

Product NDC: 54111-111
11-digit product format: 541110111
Labeler code: 54111
Product ID: 54111-111_f950bc10-183f-47f4-a3ad-3ca331dfc48d
Type: HUMAN OTC DRUG
Nonproprietary name: SALICYLIC ACID
Dosage form: GEL
Route: TOPICAL
Labeler: Bentley Laboratories, LLC
Application: part333D
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2013-10-01
Marketing end: 0000-00-00
Substance: SALICYLIC ACID
Active strength: 2 g/100g
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	54111-111		I	Inactivated by FDA		2026-10-12
excluded package	package	54111-111	54111-111-50	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	54111-111-50	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	54111-111-50	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	54111-111-50	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	54111-111-50	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	54111-111-50	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	54111-111-50	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	54111-111-50	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	54111-111-50	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	54111-111-50	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	54111-111-50	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	54111-111-50	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	54111-111-50	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	54111-111-50	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	54111-111-50	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	54111-111-50	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	54111-111-50	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	54111-111-50	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	54111-111-50	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	54111-111-50	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	54111-111-50	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	54111-111-50	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
54111-111-50	2020-01-31	C162847	48780-1	9d75b9d0-98e9-f424-e053-dadaa90a57ce	bec7cada-bc5f-47f9-bd99-5eb51077e8e3

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
54111-111-50	BRODA Acne Spa	100 g in 1 TUBE	GEL	100		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
LAURETH-4	INACTIVE INGREDIENT	6HQ855798J	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
POLOXAMER 407	INACTIVE INGREDIENT	TUF2IVW3M2	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
54111-111	BRODA ACNE SPA (SALICYLIC ACID) GEL [BENTLEY LABORATORIES, LLC]	2	Legacy NDC, 1 package rows	20181220_bec7cada-bc5f-47f9-bd99-5eb51077e8e3.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
O414PZ4LPZ	SALICYLIC ACID	69-72-7	SALICYLIC ACID

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1543172	Broda Acne Spa 2 % Topical Gel	PSN	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2
346298	salicylic acid 2 % Topical Gel	PSN	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2
1543172	salicylic acid 0.02 MG/MG Topical Gel [Broda Acne Spa]	SBD	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2
346298	salicylic acid 0.02 MG/MG Topical Gel	SCD	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2
1543172	Broda Acne Spa 0.02 MG/MG Topical Gel	SY	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2
1543172	Broda Acne Spa 2 % Topical Gel	SY	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2
346298	salicylic acid 2 % Topical Gel	SY	bec7cada-bc5f-47f9-bd99-5eb51077e8e3	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
54111-111-50	54111011150	100 g in 1 TUBE	100 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
BRODA Acne Spa - Bentley Laboratories, LLC	Bentley Laboratories, LLC	2018-12-19	HUMAN OTC DRUG LABEL	2